Krabbe Disease: Prospects of Finding a Cure Using AAV Gene Therapy

Krabbe Disease (KD) is an autosomal metabolic disorder that affects both the central and peripheral nervous systems. It is caused by a functional deficiency of the lysosomal enzyme, galactocerebrosidase (GALC), resulting in an accumulation of the toxic metabolite, psychosine. Psychosine accumulation...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gibran Nasir, Rajiv Chopra, Fiona Elwood, Seemin S. Ahmed
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/075dde463a2647d8bec66eeb56a8de50
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:075dde463a2647d8bec66eeb56a8de50
record_format dspace
spelling oai:doaj.org-article:075dde463a2647d8bec66eeb56a8de502021-11-12T13:24:16ZKrabbe Disease: Prospects of Finding a Cure Using AAV Gene Therapy2296-858X10.3389/fmed.2021.760236https://doaj.org/article/075dde463a2647d8bec66eeb56a8de502021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fmed.2021.760236/fullhttps://doaj.org/toc/2296-858XKrabbe Disease (KD) is an autosomal metabolic disorder that affects both the central and peripheral nervous systems. It is caused by a functional deficiency of the lysosomal enzyme, galactocerebrosidase (GALC), resulting in an accumulation of the toxic metabolite, psychosine. Psychosine accumulation affects many different cellular pathways, leading to severe demyelination. Although there is currently no effective therapy for Krabbe disease, recent gene therapy-based approaches in animal models have indicated a promising outlook for clinical treatment. This review highlights recent findings in the pathogenesis of Krabbe disease, and evaluates AAV-based gene therapy as a promising strategy for treating this devastating pediatric disease.Gibran NasirRajiv ChopraFiona ElwoodSeemin S. AhmedFrontiers Media S.A.articleKrabbe disease (globoid cell leukodystrophy)leukodystrophiesadeno-associated virusgene therapygalactocerebrosidasepsychosineMedicine (General)R5-920ENFrontiers in Medicine, Vol 8 (2021)
institution DOAJ
collection DOAJ
language EN
topic Krabbe disease (globoid cell leukodystrophy)
leukodystrophies
adeno-associated virus
gene therapy
galactocerebrosidase
psychosine
Medicine (General)
R5-920
spellingShingle Krabbe disease (globoid cell leukodystrophy)
leukodystrophies
adeno-associated virus
gene therapy
galactocerebrosidase
psychosine
Medicine (General)
R5-920
Gibran Nasir
Rajiv Chopra
Fiona Elwood
Seemin S. Ahmed
Krabbe Disease: Prospects of Finding a Cure Using AAV Gene Therapy
description Krabbe Disease (KD) is an autosomal metabolic disorder that affects both the central and peripheral nervous systems. It is caused by a functional deficiency of the lysosomal enzyme, galactocerebrosidase (GALC), resulting in an accumulation of the toxic metabolite, psychosine. Psychosine accumulation affects many different cellular pathways, leading to severe demyelination. Although there is currently no effective therapy for Krabbe disease, recent gene therapy-based approaches in animal models have indicated a promising outlook for clinical treatment. This review highlights recent findings in the pathogenesis of Krabbe disease, and evaluates AAV-based gene therapy as a promising strategy for treating this devastating pediatric disease.
format article
author Gibran Nasir
Rajiv Chopra
Fiona Elwood
Seemin S. Ahmed
author_facet Gibran Nasir
Rajiv Chopra
Fiona Elwood
Seemin S. Ahmed
author_sort Gibran Nasir
title Krabbe Disease: Prospects of Finding a Cure Using AAV Gene Therapy
title_short Krabbe Disease: Prospects of Finding a Cure Using AAV Gene Therapy
title_full Krabbe Disease: Prospects of Finding a Cure Using AAV Gene Therapy
title_fullStr Krabbe Disease: Prospects of Finding a Cure Using AAV Gene Therapy
title_full_unstemmed Krabbe Disease: Prospects of Finding a Cure Using AAV Gene Therapy
title_sort krabbe disease: prospects of finding a cure using aav gene therapy
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/075dde463a2647d8bec66eeb56a8de50
work_keys_str_mv AT gibrannasir krabbediseaseprospectsoffindingacureusingaavgenetherapy
AT rajivchopra krabbediseaseprospectsoffindingacureusingaavgenetherapy
AT fionaelwood krabbediseaseprospectsoffindingacureusingaavgenetherapy
AT seeminsahmed krabbediseaseprospectsoffindingacureusingaavgenetherapy
_version_ 1718430413391659008